Galectin Therapeutics (GALT) Long-Term Investments (2014)
Galectin Therapeutics (GALT) posted quarterly Long-Term Investments of $400000.0 for Q3 2014, up 534.92% quarter-over-quarter from $63000.0 in Q2 2014.
Galectin Therapeutics (GALT) Long-Term Investments (2014) Analysis & Trends
Galectin Therapeutics' Long-Term Investments history runs 1 years deep, the most recent figure standing at $400000.0 for Q3 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 5.79 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 9.83 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 372.10 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 22.17 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Galectin Therapeutics | 226.55 Mn | 226.55 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2014 | 400,000.00 |
| Jun 30, 2014 | 63,000.00 |
| Mar 31, 2014 | 130,000.00 |